PEP-Therapy Raises €2.6M in Series A Extension Financing

20 Jul, 2021

PEP-Therapy Raises €2.6M in Series A Extension Financing
Photo by Pineapple Supply Co. on Unsplash

– PEP-Therapy, a biotechnology company based in Paris, raised €3m in Series A funding.
– The funding was led by Anaxago, i&i Prague and BADGE as well as a €1m loan from Bpifrance.
– The company intends to use the funds to finance the Phase I a/b clinical trial of PEP-010, its lead candidate, for the treatment of advanced solid tumors.

Biotechnology Medical Therapeutics Western Europe
Crunchbase icon

Content report

The following text will be sent to our editors: